newsfilter
← Latest News
PR Newswire·

Genprex Issues Stockholder Letter and Provides 2025 Corporate Update

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for...